e-learning
resources
Munich 2006
Sunday 03.09.2006
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting intrapulmonary aerosol delivery of the bacterial efflux pump inhibitor MP-601,205 for CF
D. E. Geller, K. C. Kesser (Orlando, United States Of America)
Source:
Annual Congress 2006 - Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session:
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session type:
Thematic Poster Session
Number:
1517
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. E. Geller, K. C. Kesser (Orlando, United States Of America). Predicting intrapulmonary aerosol delivery of the bacterial efflux pump inhibitor MP-601,205 for CF. Eur Respir J 2006; 28: Suppl. 50, 1517
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis
Source: Eur Respir J 2002; 19: 294-302
Year: 2002
Application of 99mTc-DTPA aerosol in evaluation of pulmonary epithelial permeability
Source: Eur Respir J 2003; 22: Suppl. 45, 593s
Year: 2003
A human lung reperfusion model for monitoring the initial pulmonary absorption of drugs from aerosol devices
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005
Microbial evaluation of proton pump inhibitors and the risk of pneumonia
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011
Effect of n-butyldeoxynojirimycin on chloride efflux from CF airway epithelial cells
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 375s
Year: 2002
Nasal transepithelial potential difference does not reflect beta2-adrenergic stimulation of transepithelial sodium transport-driven alveolar fluid clearance in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 257s
Year: 2001
The state of mucociliary transport in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 418s
Year: 2004
Minimizing aerosol leakage for nebulizer treatment in the COVID-19 pandemic
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Terbutaline increased fluid transport and surfactant secretion in a rat whole lung lavage model
Source: Eur Respir J 2006; 28: Suppl. 50, 423s
Year: 2006
Augmented susceptibility to hyperoxia-induced pulmonary edema in mice with deficient amiloride-sensitive sodium transport-dependent alveolar fluid clearance
Source: Eur Respir J 2001; 18: Suppl. 33, 317s
Year: 2001
Pulmonary epithelial permeability with 99mTc-DTPA aerosol in patients with spontaneous pneumothorax
Source: Eur Respir J 2003; 22: Suppl. 45, 592s
Year: 2003
High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects
Source: Eur Respir J 2004; 23: 916-920
Year: 2004
Laninamivir’s prolonged intrapulmonary retention: Intrapulmonary pharmacokinetics (PK) and the intracellular disposition to support the long-lasting efficacy after an inhaled administration of its prodrug laninamivir octanoate (LO)
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Aerosolized perfluorocarbon improves gas exchange and reduces lung injury more effectively than high frequency oscillatory ventilation
Source: Eur Respir J 2002; 20: Suppl. 38, 37s
Year: 2002
Pulmonary surfactant as drug delivery system to target lung epithelium: new approach for the treatment of epithelial injury after bleomycin challenge
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis lung
Source: Eur Respir J 2016; 47:1392-1401
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept